HCAT Stock Recent News

SALT LAKE CITY , Aug. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has successfully completed its acquisition of Lumeon Limited ("Lumeon"), a digital health company with operations in the U.S. and United Kingdom dedicated to helping provider organizations mend broken care coordination processes through automated care orchestration. Leading providers in the U.S. and the United Kingdom use Lumeon's Care Orchestration technology to lower costs, optimize clinician and staff time, enhance revenue, and improve quality and patient safety.

Health Catalyst, Inc. (NASDAQ:HCAT ) Q2 2024 Earnings Conference Call August 7, 2024 5:00 PM ET Company Participants Jack Knight - VP, IR Dan Burton - CEO & Director Dan LeSueur - COO Jason Alger - CFO Conference Call Participants Stephanie Davis - Barclays Anne Samuel - JPMorgan Jared Haase - William Blair Sameer Patel - Evercore ISI Richard Close - Canaccord Genuity John Ransom - Raymond James Jessica Tassan - Piper Sandler Jenny Shen - BTIG Jack Wallace - Guggenheim Securities Stan Berenshteyn - Wells Fargo Jeff Garro - Stephens Operator Welcome to the Health Catalyst Second Quarter 2024 Earnings Conference Call. At this time all participants have been placed on a listen-only mode, and the floor will be open for your questions, following the presentation.

The headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Health Catalyst (HCAT) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.05 per share a year ago.

SALT LAKE CITY, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2024.

SALT LAKE CITY , July 18, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst" or the "Company") (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has entered into a five-year term loan facility for up to  $225,000,000 (the "Credit Facility" or the "Financing") with Silver Point Finance, the direct lending business of Silver Point Capital, L.P.  The Financing consists of (i) an initial term loan facility in an aggregate principal amount of $125,000,000 (the "Initial Facility") and (ii) a delayed draw term loan facility (the "Delayed Draw Facility") in an aggregate principal amount of $100,000,000.

Healthcare portfolios include telehealth stocks, notably after the COVID-19 pandemic, which increased global telemedicine usage, demonstrating their importance for lockdowns and other social isolation scenarios. The worldwide telehealth market was $122.2 billion in 2023 and is anticipated to rise 28.4% annually from 2024 to 2032.

SALT LAKE CITY , June 6, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has successfully completed its acquisition of Carevive Systems ("Carevive"), a leading oncology-focused health technology company centered on understanding and improving the experience of patients with cancer. Oncology providers and life science researchers use Carevive's flagship platform and/or Carevive data in routine clinical practice for treatment care planning, clinical trial screening, care coordination, remote patient monitoring, and/or post-treatment care.

SALT LAKE CITY, May 30, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Jason Alger, Chief Financial Officer, and Jack Knight, Vice President of Investor Relations, will participate in the following upcoming investor conferences:

Health Catalyst (HCAT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.